Carlos Gonzalez
Affiliations: | Pharmacology | University of California, San Diego, La Jolla, CA |
Google:
"Carlos Gonzalez"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhuang C, Yang S, Gonzalez CG, et al. (2024) A novel gain-of-function phosphorylation site modulates PTPN22 inhibition of TCR signaling. The Journal of Biological Chemistry. 107393 |
| Gonzalez CG, Stevens TW, Verstockt B, et al. (2024) Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab. Inflammatory Bowel Diseases |
| Sauceda C, Bayne C, Sudqi K, et al. (2022) Stool multi-omics for the study of host-microbe interactions in inflammatory bowel disease. Gut Microbes. 14: 2154092 |
| Gonzalez CG, Mills RH, Zhu Q, et al. (2022) Location-specific signatures of Crohn's disease at a multi-omics scale. Microbiome. 10: 133 |
| Gonzalez CG, Mills RH, Kordahi MC, et al. (2022) The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients. Cellular and Molecular Gastroenterology and Hepatology |
| Wedegaertner H, Pan WA, Gonzalez CC, et al. (2021) The α-arrestin ARRDC3 is an Emerging Multifunctional Adaptor Protein in Cancer. Antioxidants & Redox Signaling |